Glucotrack, Inc.
For the period ended Dec 31, 2025. Filed Mar 30, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 30, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| GLUCOTRACK, INC. | |||
| Date: | March 30, 2026 | By: | /s/ Paul Goode |
|---|---|---|---|
| Name: | Paul Goode | ||
| Title: | Chief Executive Officer | ||
| (Principal Executive Officer) | |||
| Date: | March 30, 2026 | By: | /s/ Peter Wulff |
|---|---|---|---|
| Name: | Peter Wulff | ||
| Title: | Chief Financial Officer | ||
| (Principal Financial and Accounting Officer) | |||
Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Paul Goode | Chief Executive Officer and Director | March 30, 2026 |
| Paul Goode | (Principal Executive Officer) | |
| /s/ Peter Wulff | Chief Financial Officer | March 30, 2026 |
| Peter Wulff | (Principal Financial and Accounting Officer) | |
| /s/ Erin Carter | Director | March 30, 2026 |
| Erin Carter | ||
| /s/ Luis Malave | Director | March 30, 2026 |
| Luis Malave | ||
| /s/ Andrew Balo | Director | March 30, 2026 |
| Andrew Balo | ||
| /s/ Victoria Carr-Brendel | Director | March 30, 2026 |
| Victoria Carr-Brendel | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.